Matches in Nanopublications for { ?s ?p "[Because solid tumors expressing ECGF-1 could also be lysed by the CTL, ECGF-1 is an interesting target for immunotherapy of both hematologic and solid tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- assertion description "[Because solid tumors expressing ECGF-1 could also be lysed by the CTL, ECGF-1 is an interesting target for immunotherapy of both hematologic and solid tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Because solid tumors expressing ECGF-1 could also be lysed by the CTL, ECGF-1 is an interesting target for immunotherapy of both hematologic and solid tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP390323.RA464OC3ngPYI2Rh8g7JbpPDlydVWl9UJE86fuaSzICfc130_assertion description "[Because solid tumors expressing ECGF-1 could also be lysed by the CTL, ECGF-1 is an interesting target for immunotherapy of both hematologic and solid tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP390323.RA464OC3ngPYI2Rh8g7JbpPDlydVWl9UJE86fuaSzICfc130_provenance.
- NP913910.RAyk4yYZF8ekjlbO5Jx5Z-2_g7m5Sy7n0j9B_n8pJbWF0130_assertion description "[Because solid tumors expressing ECGF-1 could also be lysed by the CTL, ECGF-1 is an interesting target for immunotherapy of both hematologic and solid tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP913910.RAyk4yYZF8ekjlbO5Jx5Z-2_g7m5Sy7n0j9B_n8pJbWF0130_provenance.
- NP364338.RAW1NfDrQBm-Ri3nB83IrSpgjNz8IgMpGG_n3anKVml7U130_assertion description "[Because solid tumors expressing ECGF-1 could also be lysed by the CTL, ECGF-1 is an interesting target for immunotherapy of both hematologic and solid tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP364338.RAW1NfDrQBm-Ri3nB83IrSpgjNz8IgMpGG_n3anKVml7U130_provenance.
- NP537237.RAVVACyEk4lJA9BNNkVBeFVolKswfGZ6RXy_UdGYg6Fo8130_assertion description "[Because solid tumors expressing ECGF-1 could also be lysed by the CTL, ECGF-1 is an interesting target for immunotherapy of both hematologic and solid tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP537237.RAVVACyEk4lJA9BNNkVBeFVolKswfGZ6RXy_UdGYg6Fo8130_provenance.
- NP537236.RAgOlVUWYSijnXW8w2Pa7MNfV6Oh6gkJYLjLa_ifqV13E130_assertion description "[Because solid tumors expressing ECGF-1 could also be lysed by the CTL, ECGF-1 is an interesting target for immunotherapy of both hematologic and solid tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP537236.RAgOlVUWYSijnXW8w2Pa7MNfV6Oh6gkJYLjLa_ifqV13E130_provenance.
- NP363978.RAJFYdw0AjRC6KCoIUSkYzcU3ygDDKokqy-JWa4FjiM1s130_assertion description "[Because solid tumors expressing ECGF-1 could also be lysed by the CTL, ECGF-1 is an interesting target for immunotherapy of both hematologic and solid tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP363978.RAJFYdw0AjRC6KCoIUSkYzcU3ygDDKokqy-JWa4FjiM1s130_provenance.